This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes. A thought-provoking look at where terminology meets bedside care.
Moderator: Tom Marjot 
Speakers: Paolo Angeli and Julia Wendon
This EASL Studio is supported by GENFIT. EASL has received no input from GENFIT with regards to the content of this programme. 
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.

Ver todos los episodios